Enhancing the R&D ecosystem to propel Malaysia as a global biotechnology hub
Biotechnology for economic growth and environmental sustainability
Promoting the nation’s prosperity through biotechnology
Implementation of STI towards the creation of a scientifically advanced nation
Contact Us
Previous
Next

INNOVATION FOR THE NEW ECONOMY

NIBM is committed towards delivering industry-driven solutions through science & biotechnology towards a sustainable & thriving Malaysian bio-based economy.

  • National Institutes of Biotechnology Malaysia

At a glance…

In 2005, the National Biotechnology Policy (NBP) was launched with the aim to make biotechnology as a new economic engine for the country. Among the many initiatives taken was to upgrade the three biotechnology cooperative centers (BCC) set up in 2002 into National Biotechnology Institutes in 2006. The BCCs were then named as Malaysian Institute of Pharmaceuticals & Nutraceuticals (IPHARM), Agro-Biotechnology Institute Malaysia (ABI), and Malaysia Genome Institute (MGI).

  • CEO Messages
"We Bring Science in Biotechnology to the Marketplace Through the Nurturing Of Biotech Companies and Creation of A Holistic Ecosystem For The Industry’s Growth"
Redzuan Sofian
Chief Executive Officer
Prof. Dr. Shahrul Hisham Zainal Ariffin
Prof. Dr. Shahrul Hisham Zainal AriffinDirector of Malaysia Genome Institute
Read More
" Everything that human beings or living animals do is done by protein molecules. And therefore the kind of proteins that one has and therefore the ability one has is determined by the genes that one has "​
Assoc. Prof. Dr. Norihan Saleh
Assoc. Prof. Dr. Norihan SalehDirector of Agro-biotechnology Institute
Read More
" Biology is the study of the complex things in the Universe. Physics is the study of the simple ones. If physics and biology one day meet, and one of the two is swallowed up, that one will be biology. "
  • News / Event / Announcements
  • Corporate Profile

National Institutes of Biotechnology Malaysia (NIBM) to lead, coordinate and implement the national biotechnology agenda through activities research, development, innovation and commercialization (RDIC).

MGI

ABI

IPHARM